Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

1YCS

P53-53BP2 COMPLEX

Summary for 1YCS
Entry DOI10.2210/pdb1ycs/pdb
DescriptorP53, 53BP2, ZINC ION, ... (4 entities in total)
Functional Keywordsankyrin repeats, sh3, p53, tumor suppressor, multigene family, nuclear protein, phosphorylation, disease mutation, polymorphism, complex (anti-oncogene-ankyrin repeats), complex (anti-oncogene-ankyrin repeats) complex, complex (anti-oncogene/ankyrin repeats)
Biological sourceHomo sapiens (human)
More
Total number of polymer chains2
Total formula weight49457.41
Authors
Gorina, S.,Pavletich, N.P. (deposition date: 1996-09-30, release date: 1997-11-19, Last modification date: 2024-02-14)
Primary citationGorina, S.,Pavletich, N.P.
Structure of the p53 tumor suppressor bound to the ankyrin and SH3 domains of 53BP2.
Science, 274:1001-1005, 1996
Cited by
PubMed Abstract: Mutations in the p53 tumor suppressor are among the most frequently observed genetic alterations in human cancer and map to the 200-amino acid core domain of the protein. The core domain contains the sequence-specific DNA binding activity and the in vitro 53BP2 protein binding activity of p53. The crystal structure of the p53 core domain bound to the 53BP2 protein, which contains an SH3 (Src homology 3) domain and four ankyrin repeats, revealed that (i) the SH3 domain binds the L3 loop of p53 in a manner distinct from that of previously characterized SH3-polyproline peptide complexes, and (ii) an ankyrin repeat, which forms an L-shaped structure consisting of a beta hairpin and two alpha helices, binds the L2 loop of p53. The structure of the complex shows that the 53BP2 binding site on the p53 core domain consists of evolutionarily conserved regions that are frequently mutated in cancer and that it overlaps the site of DNA binding. The six most frequently observed p53 mutations disrupt 53BP2 binding in vitro. The structure provides evidence that the 53BP2-p53 complex forms in vivo and may have a critical role in the p53 pathway of tumor suppression.
PubMed: 8875926
DOI: 10.1126/science.274.5289.1001
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.2 Å)
Structure validation

239492

PDB entries from 2025-07-30

PDB statisticsPDBj update infoContact PDBjnumon